<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00877669</url>
  </required_header>
  <id_info>
    <org_study_id>2008-10-038</org_study_id>
    <nct_id>NCT00877669</nct_id>
  </id_info>
  <brief_title>Efficacy Study of HoLEP and TURP on LUTS Secondary to BPH</brief_title>
  <official_title>The Comparison of Efficacy Between Holmium Laser Enucleation of the Prostate (HoLEP) and Transurethral Resection of the Prostate (TURP) on the Lower Urinary Tract Symptoms (LUTS) Secondary to Benign Prostate Hyperplasia (BPH)</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Samsung Medical Center</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Samsung Medical Center</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this study is to compare of Efficacy and Safety Between Holmium Laser
      Enucleation of the Prostate (HoLEP) and Transurethral Resection of the Prostate (TURP) on the
      Lower Urinary Tract Symptoms (LUTS) Secondary to Benign Prostate Hyperplasia (BPH).
    </textblock>
  </brief_summary>
  <overall_status>Unknown status</overall_status>
  <last_known_status>Recruiting</last_known_status>
  <start_date>October 2008</start_date>
  <completion_date type="Anticipated">September 2015</completion_date>
  <primary_completion_date type="Anticipated">September 2015</primary_completion_date>
  <phase>Phase 2</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>The changes of International Prostatic Symptom Scores (IPSS) from baseline to 6 months after operation</measure>
    <time_frame>6 months</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>The changes of Quality of Life (QoL) parameters</measure>
    <time_frame>6 months</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>The changes of IPSS and QoL parameters</measure>
    <time_frame>1 month and 3months after operation</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>The changes of Uroflowmetry (UFM) and Postvoid residual urine(PVR) parameters</measure>
    <time_frame>2 weeks and 3 and 6 months after operation</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Postoperative hospital stay days and postoperative catheterization days</measure>
    <time_frame>immediate postoperative period</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>The changes of the hemoglobin and the serum sodium</measure>
    <time_frame>0 and 1 day after operation</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Operative time and Resected tissue weight</measure>
    <time_frame>0 day after operation</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>The changes of ICS male questionnaire (short form) parameters</measure>
    <time_frame>3 and 6 months after operation</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>The changes of international index of erectile function (IIEF)-15 parameters</measure>
    <time_frame>6 months after operation</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>The changes of Patient perception of treatment benefit questionnaire (PPTB) parameters</measure>
    <time_frame>3 and 6 months after operation</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>The changes of voiding frequencies and urgency parameters in Frequency volume chart</measure>
    <time_frame>3 and 6 months after operation</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Ejaculation parameter</measure>
    <time_frame>6 months after operation</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Complications</measure>
    <time_frame>During all study periods</time_frame>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">116</enrollment>
  <condition>Lower Urinary Tract Symptoms</condition>
  <condition>Benign Prostatic Hyperplasia</condition>
  <arm_group>
    <arm_group_label>Transurethral resection of the prostate</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>TURP group</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Holmium Laser Enucleation of Prostate</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>HoLEP group</description>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Transurethral resection of the prostate</intervention_name>
    <description>Standard transurethral resection of the prostate using electrocautery loop</description>
    <arm_group_label>Transurethral resection of the prostate</arm_group_label>
    <other_name>TURP</other_name>
  </intervention>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Holmium Laser Enucleation of the Prostate</intervention_name>
    <description>HoLEP using 100W Ho:YAG laser</description>
    <arm_group_label>Holmium Laser Enucleation of Prostate</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  50 yrs or greater

          -  International prostatic symptom score &gt;= 12

          -  Bladder outlet obstruction confirmed by pressure-flow study (BOOI &gt; 20)

          -  Able to give fully informed consent

        Exclusion Criteria:

          -  Patients with urologic malignancies such as prostate cancer and bladder cancer

          -  Patients underwent urethral, prostate surgery

          -  Patients with urethral stricture or bladder diverticulum or bladder neck contracture

          -  Patients with histories of bacterial prostatitis within 1 year

          -  seems not to be appropriate to this study by the decision of investigators because of
             any other reasons
      </textblock>
    </criteria>
    <gender>Male</gender>
    <minimum_age>50 Years</minimum_age>
    <maximum_age>80 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Kyu-Sung Lee, Ph.D.,M.D.</last_name>
    <role>Principal Investigator</role>
    <affiliation>Samsung Medical Center</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Kyu-Sung Lee, Ph.D, M.D.</last_name>
    <phone>82-2-3410-3554</phone>
    <email>ksleedr@skku.edu</email>
  </overall_contact>
  <location>
    <facility>
      <name>Samsung Medical Center</name>
      <address>
        <city>Seoul</city>
        <country>Korea, Republic of</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Kyu-Sung Lee, Ph.D.,M.D.</last_name>
      <phone>82-2-3410-3554</phone>
      <email>ksleedr@skku.edu</email>
    </contact>
    <contact_backup>
      <last_name>Deok Hyun Han, M.D.</last_name>
      <phone>82-2-3410-3559</phone>
      <email>deokhyun.han@samsung.com</email>
    </contact_backup>
    <investigator>
      <last_name>Kyu-Sung Lee, Ph.d.,M.D.</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Deok Hyun Han, M.D.</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>Korea, Republic of</country>
  </location_countries>
  <verification_date>January 2014</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>April 6, 2009</study_first_submitted>
  <study_first_submitted_qc>April 7, 2009</study_first_submitted_qc>
  <study_first_posted type="Estimate">April 8, 2009</study_first_posted>
  <last_update_submitted>February 12, 2015</last_update_submitted>
  <last_update_submitted_qc>February 12, 2015</last_update_submitted_qc>
  <last_update_posted type="Estimate">February 16, 2015</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Samsung Medical Center</investigator_affiliation>
    <investigator_full_name>KYU-SUNG LEE</investigator_full_name>
    <investigator_title>Urology, Professor</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Hyperplasia</mesh_term>
    <mesh_term>Prostatic Hyperplasia</mesh_term>
    <mesh_term>Lower Urinary Tract Symptoms</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

